Icaritin Inhibits JAK/STAT3 Signaling and Growth of Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Icaritin Inhibits JAK/STAT3 Signaling and Growth of Renal Cell Carcinoma

Published:2013-12-06 Issue:12 Volume:8 Page:e81657
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Li Shasha,Priceman Saul J.,Xin Hong,Zhang Wang,Deng Jiehui,Liu Yong,Huang Jiabin,Zhu Wenshan,Chen Mingjie,Hu Wei,Deng Xiaomin,Zhang Jian,Yu Hua,He Guangyuan

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference55 articles.

1. The epidemiology of renal cell carcinoma;B Ljungberg;Eur Urol,2011

2. Randomized phase II trial of first-line treatment with sorafenib versus interferon Alfa-2a in patients with metastatic renal cell carcinoma;B Escudier;J Clin Oncol,2009

3. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;RJ Motzer;N Engl J Med,2007

4. Sorafenib in advanced clear-cell renal-cell carcinoma;B Escudier;N Engl J Med,2007

5. Phase I/II trial of temsirolimus combined with interferon alfa for advanced renal cell carcinoma;RJ Motzer;J Clin Oncol,2007

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted nanomedicine modulating intercellular communications to arrest renal cell carcinoma progression;Journal of Drug Delivery Science and Technology;2024-09

2. Cancer-Related Therapeutic Potential of Epimedium and Its Extracts;Nutrition and Cancer;2024-07-26

3. Research on molecular characteristics of ADME-related genes in kidney renal clear cell carcinoma;Scientific Reports;2024-07-22

4. The role of natural products versus miRNA in renal cell carcinoma: implications for disease mechanisms and diagnostic markers;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-05-01

5. Listeria-vectored cervical cancer vaccine candidate strains reduce MDSCs via the JAK-STAT signaling pathway;BMC Biology;2024-04-19